EXTON, PA / ACCESSWIRE / January 13, 2025 / Frontage Holdings Corporation (SEHK stock code:1521) announced on January 6 2025 that Dr. Abdul Mutlib has decided t
EXTON, Pa., Feb. 1, 2024 /PRNewswire/ -- Frontage Holdings Corporation is pleased to announce that Mr. Henry Gao has been appointed as its Chief Financial Officer , effective February 1, 2024. ...
/PRNewswire/ -- The "Global Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule,...
/PRNewswire/ -- Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has been promoted to CEO of the company, a role in which he succeeds...
/PRNewswire/ -- Frontage Laboratories, Inc. ("Frontage") completed the acquisition of Frontage Clinical Services Inc. ("Frontage Clinical"), a clinical Phase...
DUBLIN, March 25, 2022 The "Clinical Trials Market by Phase (Phase I, II, III), Service Type (Site Identification, Laboratory Services, Decentralized Clinical...